Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Orthofix International (OFIX) Tops Q4 EPS by 25c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
February 26, 2021 7:04 AM ESTOrthofix International (NASDAQ: OFIX) reported Q4 EPS of $0.44, $0.25 better than the analyst estimate of $0.19. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $113.2 million.
Fourth quarter net sales of $117.6 million, within 3% of our 2019 resultsUS Spine implant sales grew 11% compared to fourth quarter 2019, driven by record M6-C artificial cervical disc performanceStrong cash flow performance in the quarter, free cash flow of $17.9 millionFITBONE® intramedullary lengthening and deformity system receives FDA clearance for pediatric indicationWe were very pleased with our performance during... More
